Related Experiment Video

Updated: May 31, 2026

Profiling Ubiquitin and Ubiquitin-like Dependent Post-translational Modifications and Identification of Significant Alterations
10:26

Profiling Ubiquitin and Ubiquitin-like Dependent Post-translational Modifications and Identification of Significant Alterations

Published on: November 7, 2019

WWP2 ubiquitin ligase and its isoforms: new biological insight and promising disease targets

Andrew Chantry1

  • 1School of Biological Sciences, University of East Anglia, Norwich, UK. a.chantry@uea.ac.uk

Cell Cycle (Georgetown, Tex.)
|July 14, 2011
PubMed

Insights

The WWP2 E3 ubiquitin ligase and its novel isoforms play key roles in cell regulation and development. Targeting WWP2 offers potential for treating osteoarthritis and cancer.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Recent studies highlight the WWP2 E3 ubiquitin ligase and its novel isoforms.
  • These have provided significant biological insights and disease-specific functions.
  • Their roles in cell cycle regulation, apoptosis, and differentiation are increasingly understood.

Purpose of the Study:

  • To explore the biological roles and disease relevance of WWP2 and its isoforms.
  • To investigate the potential of WWP2 as a therapeutic target for specific diseases.

Main Methods:

  • Gene knockout studies to assess developmental roles.
  • Analysis of WWP2 isoform interactions with signaling pathways.

Main Results:

  • WWP2 has a developmental role in chondrogenesis, involving cartilage-specific transcription factors.
  • WWP2 isoforms selectively target oncogenic signaling pathways, including those involving the PTEN tumor suppressor and TGFβ/Smad signaling.
  • WWP2 isoforms are identified as critical physiological regulators.

Conclusions:

  • WWP2 isoforms are emerging as key regulators in normal physiology and as promising therapeutic targets.
  • Developing selective WWP2 inhibitors is crucial for treating cartilage diseases like osteoarthritis and for novel anticancer strategies.

More Related Videos

In Vitro Analysis of E3 Ubiquitin Ligase Function06:06

In Vitro Analysis of E3 Ubiquitin Ligase Function

Published on: May 14, 2021

Comparative Strategies for Ubiquitination Detection in Mammalian Cell Lysates Using SMAD2/SMURF2 as a Model09:00

Comparative Strategies for Ubiquitination Detection in Mammalian Cell Lysates Using SMAD2/SMURF2 as a Model

Published on: April 17, 2026

Related Concept Videos

Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...